RecruitingNot applicableNCT06775561
Precision Diagnosis and Therapy for Rare Diseases by Interpreting Non-coding Genomes
Studying Neuromuscular disease
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- IRCCS Azienda Ospedaliero-Universitaria di Bologna
- Principal Investigator
- Tommaso Pippucci, BiologistIRCCS Azienda Ospedaliero-Universitaria di Bologna
- Intervention
- PARADIGM study aims to streamline the process from genomic characterization of RGD patients with ED/NMD to identification of the suitable personalized therapy.(genetic)
- Enrollment
- 100 enrolled
- Eligibility
- All sexes
- Timeline
- 2023 – 2025
Study locations (1)
- IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT06775561 on ClinicalTrials.govOther trials for Neuromuscular disease
Additional recruiting or active studies for the same condition.
- RECRUITINGNANCT06708468Personalized Training for People With Rare Neuromuscular DisordersOslo University Hospital
- RECRUITINGNANCT06363357The Effect of a Muscle-mimicking, Fabric-type Shoulder Orthosis on Functional Movements of the Upper Limb in Patients With Neuromuscular DisorderSeoul National University Hospital
- RECRUITINGNANCT06756633Respiratory Functions, Thoracoabdominal Movements and Exercise Capacity in Neuromuscular DiseasesLokman Hekim University